SCHEMBL1118052

SCHEMBL1118052

CC(N1C=CC=C(C(N)=O)C1)C(F)(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5678148 0.82 TSHR (0.30)
SCHEMBL22558903 0.81
SCHEMBL22558901 0.81
SCHEMBL9942241 0.75
SCHEMBL22121002 0.70
SCHEMBL132243 0.70 TSHR (0.32)
Trifluoromethanesulfonic Acid SCHEMBL5673706 0.69
Fluoride SCHEMBL22206791 0.68 TSHR (0.32)
Bromide SCHEMBL22206792 0.68 TSHR (0.32)
Hydrochloric Acid SCHEMBL134284 0.68 THRB (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2280966-A1 AZABICYCLO [3.2.1]OCTYL DERIVATIVES AS 11 BETA-HSD1 MODULATORS Exelixis, Inc. (US) 2011-02-09 EP claimed
WO-2009114173-A1 AZABICYCLO [3. 2. I] OCTYL DERIVATIVES AS 11 BETA-HSDL MODULATORS EXELIXIS, INC. (US) 2009-09-17 WO claimed
CN-114585614-A Non-peptide somatostatin type 5 receptor agonists and uses thereof 克林提克斯医药股份有限公司 2022-06-03 CN disclosed
EP-2978752-A1 6-(5-HYDROXY-1H-PYRAZOL-1-YL)NICOTINAMIDE DERIVATIVES AND THEIR USE AS PHD INHIBITORS Takeda Pharmaceutical Company Limited (JP) 2016-02-03 EP disclosed
WO-2014160810-A1 6-(5-HYDROXY-1H-PYRAZOL-1-YL)NICOTINAMIDE DERIVATIVES AND THEIR USE AS PHD INHIBITORS TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2014-10-02 WO disclosed